Internal Med

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

A new study raises fresh safety concerns about widely used anemia medicines, finding that the drug Aranesp nearly doubled the risk of stroke in people with diabetes and chronic kidney problems who are not yet sick enough to need dialysis. The study is the largest ever of these blood–boosting drugs and the only one that compared them to a dummy treatment. The medicines have become blockbuster sellers because they lessen the need for transfusions, but their ability to prevent heart attacks, kidney failure or other problems have not been proven.

   

Today in Popular Press...keeping you current

Polymer therapeutic protects gut from radiation damage, infection after cancer treatment
EurekAlert, 12/04/09

Exposure to Secondhand Cigarette Smoke Over a Lifetime Increased Breast Cancer Risk Later in Life
ScienceDaily, 12/04/09

New mental treatment improves anxiety and depression in secondary education teachers
ScienceDaily, 12/04/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address